Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

The Anti-Rotaviral and Anti-Inflammatory Effects of Hyrtios and Haliclona Species

  • Koh, Su-Im (College of Pharmacy, Duksung Women's University) ;
  • Shin, Hea-Soon (College of Pharmacy, Duksung Women's University)
  • Received : 2016.05.30
  • Accepted : 2016.07.25
  • Published : 2016.11.28
Download PDF
⟨ Previous Next ⟩

Abstract

The marine sponges Hyrtios and Haliclona species, both of which are known to produce secondary bioactive metabolites, were used to extract 1304KO-327 and 1304KO-328. Such secondary metabolites are potentially antibacterial, antiviral, anti-inflammatory, antitumoral, antifungal, and antiplasmodial. In the present study, the effects of 1304KO-327 and 1304KO-328 were studied for their clinical and pathological importance. The cytotoxicity of 1304KO-327 and 1304KO-328 was assessed via MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay on HT-29, Caco-2, and Raw 264.7 cells. Rotavirus-infected Caco-2 cells were used to prove the antiviral effects of the marine sponge extracts. The test results cogently proved that the virus-inhibiting effects of the sponge extracts improved with extract concentration. Anti-inflammatory effects of the marine sponge extracts were tested on Lipopolysaccharide-treated Raw 264.7 cells. Nitric oxide and cytokine were produced by treatment of the cells with LPS and the inhibiting effects of the sponge extracts on $IL-1{\beta}$ formation were investigated. This study found that the NO production was decreased dose dependently, and $IL-1{\beta}$ formation was significantly reduced by the marine sponge extracts.

Keywords

References

  1. Anderson AP, Beveridge AA, Capon R. 1994. Pharmacological properties of the natural marine product furospongin-1. Clin. Exp. Pharmacol. Physiol. 12: 945-953.
  2. Aratake S, Trianto A, Hanif N, de Voogd NJ, Tanaka J. 2009. A new polyunsaturated brominated fatty acid from a Haliclona sponge. Mar. Drugs 4: 523-527.
  3. Ankisetty S, Slattery M. 2012. Antibacterial secondary metabolites from the cave sponge Xestospongia sp. Mar. Drugs. 10: 1037- 1043. https://doi.org/10.3390/md10051037
  4. Acosta AL, Rodriguez AD. 1992. 11-Oxoaerothionin: a cytotoxic antitumor bromotyrosine-derived alkaloid from the Caribbean marine sponge Aplysina lacunosa. J. Nat. Prod. 7: 1007-1012.
  5. Blunt JW, Copp BR, Hu WP, Munro MH, Northcote PT, Prinsep MR. 2008. Marine natural products. Nat. Prod. Rep. 25: 35-94. https://doi.org/10.1039/b701534h
  6. Blunt JW, Copp BR, Munro MH, Northcote PT, Prinsep MR. 2004. Marine natural products. Nat. Prod. Rep. 21: 1-49. https://doi.org/10.1039/b305250h
  7. Bae WR, Lim HK, Kim KM, Cho HS, Lee SY, Jeong CS, et al. 2015. Apoptosis-inducing activity of marine sponge Haliclona sp. extracts collected from Kosrae in nonsmall cell lung cancer A549 cells. Evid. Based Complement. Alternat. Med. 2015: 717959.
  8. Bines JE. Rotavirus vaccines and intussusception risk. 2005. Curr. Opin. Gastroenterol. 21: 20-25.
  9. Clark RJ, Garson MJ, Hooper JN. 2001. Antifungal alkyl amino alcohols from the tropical marine sponge Haliclona n. sp. J. Nat. Prod. 12: 1568-1571.
  10. Carter GT, Rinehart KL Jr. 1978. Acarnidines, novel antiviral and antimicrobial compounds from the sponge Acarnus erithacus (de Laubenfels). J. Am. Chem. Soc. 100: 4302-4304. https://doi.org/10.1021/ja00481a049
  11. Chow CM, Leung AKC, Hon K. 2010. Acute gastroenteritis: from guide-lines to real life. Clin. Exp. Gastroenterol. 3: 97-112. https://doi.org/10.1007/s12328-010-0138-0
  12. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, et al. 2007. Probiotics for treatment of acute diarrhoea in children: randomized clinical trial of five different preparations. BMJ 7615: 340.
  13. Cucchiara S, Falconieri P, Di Nardo G, Parcelii MA, Dito L, Grandinetti A. 2002. New therapeutic approach in the management of intestinal disease: probiotics in intestinal disease in paediatric age. Dig. Liver Dis. 2: S44-S47.
  14. Donia M, Hamann MT. 2003. Marine natural products and their potential applications as anti-infective agents. Lancet Infect. Dis. 3: 338-348. https://doi.org/10.1016/S1473-3099(03)00655-8
  15. El Amraoui B, El Amraoui M, Cohen N, Fassouane A. 2014. Antifungal and antibacterial activity of marine microorganisms. Ann. Pharm. Fr. 72: 107-111. https://doi.org/10.1016/j.pharma.2013.12.001
  16. Fontaine O, Gore SM, Pierce NF. 2000. Rice-based oral rehydration solution for treating diarrhoea. Cochrane Database Syst. Rev. CD001264.
  17. Faulkner DJ. 2002. Marine natural products. Nat. Prod. Rep. 1: 1-48.
  18. Hoppers A, Stoudenmire J, Wu S, Lopanik NB. 2014. Antibiotic activity and microbial community of the temperate sponge, Haliclona sp. J. Appl. Microbiol. 118: 419-430.
  19. Kang JY, Lee DK, Ha NJ, Shin HS. 2015. Antiviral effects of Lactobacillus ruminis SPM0211 and Bifidobacterium longum SPM1205 and SPM1206 on rotavirus-infected Caco-2 cells and a neonatal mouse model. J. Microbiol. 11: 796-803.
  20. Lim HK, Bae WR, Lee HS, Jung JH. 2014. Anticancer activity of marine sponge Hyrtios sp. extract in human colorectal carcinoma RKO cells with different p53 status. Biomed. Res. Int. 2014: 413575.
  21. Li CW, Chen JY, Hua TE. 1998. Pre Cambrian sponges with cellular structures. Science 279: 879-882. https://doi.org/10.1126/science.279.5352.879
  22. Maloof AC, Rose CV, Beach R, Samuels BM, Calmet CC, Erwin DH, et al. 2010. Possible animal-body fossils in pre- Marinoan limestones from South Australia. Nat. Geosci. 3: 653-659. https://doi.org/10.1038/ngeo934
  23. Mancini I, Defant A, Guella G. 2007. Recent synthesis of marine natural products with antibacterial activities. Antiinfect. Agents Med. Chem. 6: 17-48. https://doi.org/10.2174/187152107779314151
  24. Newbold RW, Jensen PR, Fencial W, Pawlik JR. 1999. Antimicrobial activity of Caribbean sponge extracts. Aquat. Microb. Ecol. 19: 279-284. https://doi.org/10.3354/ame019279
  25. O'Halloran JA, Barbosa TM, Morrissey JP, Kennedy J, O'Gara F, Dobson ADW. 2011. Diversity and antimicrobial activity of Pseudovibrio spp. from Irish marine sponges. J. Appl. Microbiol. 110: 1495-1508. https://doi.org/10.1111/j.1365-2672.2011.05008.x
  26. Ozuah PO, Avner JR, Stein RE. 2002. Oral rehydration, emergency physicians, and practice parameters: a national survey. Pediatrics 2: 259-261.
  27. Petchi RR, Vijaya C, Parasuraman S. 2013. Antiarthritic activity of ethanolic extract of Tridax procumbens (Linn.) in Sprague Dawley rats. Pharmacognosy Res. 5: 113-117.
  28. Randazzo A, Bifulco G, Giannini C, Bucci M, Debitus C, Cirino G, Gomez-Paloma L. 2001. Halipeptins A and B: two novel potent anti-inflammatory cyclic depsipeptides from the Vanuatu marine sponge Haliclona species. J. Am. Chem. Soc. 44: 10870-10876.
  29. Rinehart KL Jr, Gloer JB, Hughes RG Jr, Renis HE, Mcgovren JP, Swynenberg EB, et al. 1981. Didemnins: antiviral and antitumor depsipeptides from a Caribbean tunicate. Science 12: 933-935.
  30. Sheikh Y, Djerassi C. 1974. Steroids from sponges. Tetrahedron 30: 4095-4103. https://doi.org/10.1016/S0040-4020(01)97391-0
  31. Sagar S, Kaur M, Minneman KP. 2010. Antiviral lead compounds from marine sponges. Mar. Drugs 8: 2619-2638. https://doi.org/10.3390/md8102619
  32. Simmons TL, Andrianasolo E, Flatt KMP, Gerwick WH. 2005. Marine natural products as anticancer drugs. Mol. Cancer Ther. 4: 333-342.
  33. Skariyachan S, G Rao A, Patil MR, Saikia B, Bharadwaj Kn V, Rao Gs J. 2014. Antimicrobial potential of metabolites extracted from bacterial symbionts associated with marine sponges in coastal area of Gulf of Mannar Biosphere, India. Lett. Appl. Microbiol. 3: 231-241.
  34. Taylor M, Radax R, Steger D, Wagner M. 2007. Spongeassociated microorganisms. Evolution, ecology, and biotechnological potential. Microbiol. Mol. Biol. Rev. 71: 295-347. https://doi.org/10.1128/MMBR.00040-06
  35. Viegelmann C, Margassery LM, Kennedy J, Zhang T, O'Brien C, O'Gara F, et al. 2014. Metabolomic profiling and genomic study of a marine sponge-associated Streptomyces sp. Mar. Drugs 12: 3323-3351. https://doi.org/10.3390/md12063323
  36. Wattanadilok R, Sawangwong P, Rodrigues C, Cidade H, Pinto M, Pinto E, et al. 2007. Antifungal activity evaluation of the constituents of Haliclona baeri and Haliclona cymaeformis, collected from the Gulf of Thailand. Mar. Drugs 5: 40-51. https://doi.org/10.3390/md502040

Cited by

  1. Antinociceptive and Anti-inflammatory Activities of Marine Sponges Aplysina Caissara, Haliclona sp. and Dragmacidon Reticulatum vol.61, pp.None, 2016, https://doi.org/10.1590/1678-4324-2018180104
  2. Different Macrophage Type Triggering as Target of the Action of Biologically Active Substances from Marine Invertebrates vol.18, pp.1, 2020, https://doi.org/10.3390/md18010037
  3. Isoquinolinequinone Derivatives from a Marine Sponge (Haliclona sp.) Regulate Inflammation in In Vitro System of Intestine vol.19, pp.2, 2021, https://doi.org/10.3390/md19020090